JP2001302535A - Composition for medicament - Google Patents

Composition for medicament

Info

Publication number
JP2001302535A
JP2001302535A JP2000117923A JP2000117923A JP2001302535A JP 2001302535 A JP2001302535 A JP 2001302535A JP 2000117923 A JP2000117923 A JP 2000117923A JP 2000117923 A JP2000117923 A JP 2000117923A JP 2001302535 A JP2001302535 A JP 2001302535A
Authority
JP
Japan
Prior art keywords
extract
composition
powder
agaricus
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000117923A
Other languages
Japanese (ja)
Inventor
Gakuhin Yo
学斌 楊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JMC KK
Original Assignee
JMC KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JMC KK filed Critical JMC KK
Priority to JP2000117923A priority Critical patent/JP2001302535A/en
Publication of JP2001302535A publication Critical patent/JP2001302535A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a composition for medicament for health and for disease, in particular including extracts of Agaricus, Cordyceps sinensis and Ganoderma lucidum. SOLUTION: This composition concurrently including extracts of Agaricus, Cordyceps sinensis and Ganoderma lucidum effective and excellent in storage stability of properties, is obtained by adjusting pH of an aqueous solution/water dispersion of the composition in solution state or solid state article at pH 1.5-9.5.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】アガリクス茸、冬虫夏草及び霊芝
又はこれらの抽出エキスを同時に含む健康維持と疾病治
療を目的とした医療用組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical composition containing Agaricus mushroom, Cordyceps sinensis and Reishi, or an extract thereof for the purpose of maintaining health and treating diseases.

【0002】[0002]

【従来の技術】アガリクス茸、冬虫夏草又は霊芝の3剤
はそれぞれに健康維持と疾病治療上の効果が異なるので
総合的な効果又は相乗効果を得るためには相互に併用す
る必要がある。現在、各生薬についてはそれぞれの水抽
出エキスをドリンク剤、顆粒剤又は錠剤にして内服され
ているが、既存の3剤の各製剤製品を同時に服用する場
合には全体として30mLとか10g等の大きな重量又
は容量を一度に服用しなければならない。
2. Description of the Related Art Agaricus mushroom, Cordyceps sinensis and Reishi are different in their health maintenance and disease treatment effects. Therefore, they must be used together to obtain an overall effect or a synergistic effect. At present, each herbal medicine is taken as a drink, granule or tablet with each aqueous extract, but when taking each of the three existing preparations at the same time, a large amount such as 30 mL or 10 g as a whole is taken. The weight or volume must be taken at one time.

【0003】[0003]

【発明が解決しようとする課題】そこで本発明者らは、
アガリクス茸、冬虫夏草又は霊芝の各生薬の抽出エキス
を同時に含み、健康維持と疾病治療上の効果を総合的に
期待できる例えば10mLとか2g以内の適度な服用重
量又は容量の医療用組成物の製品を得るべく鋭意検討し
た。この際、3剤を同時に含む溶液状又は固体状組成物
においては、個々の既存の生薬製品と異なり、調製時、
及び溶液状製品又は固体状製品の水溶液及び水分散液の
外観や味がpHの影響を受けやすいことがわかり、製品
化に当たっては組成物のpH範囲の選択が必要であるこ
とを認識した。
SUMMARY OF THE INVENTION Accordingly, the present inventors
A product of a medical composition containing an extract of each of the herbal medicines of Agaricus mushroom, Cordyceps sinensis or Reishi, and having an appropriate dose or volume within 10 mL or 2 g, for example, which can comprehensively expect the effects of maintaining health and treating diseases. We studied diligently to obtain. At this time, in the solution or solid composition containing the three agents simultaneously, unlike the individual existing crude drug products, at the time of preparation,
It was also found that the appearance and taste of aqueous solutions and aqueous dispersions of solution products or solid products were easily affected by pH, and it was recognized that selection of the pH range of the composition was necessary for commercialization.

【0004】[0004]

【課題を解決するための手段】まず、アガリクス茸、冬
虫夏草又は霊芝の3剤を同時に含む溶液状又は固体状組
成物の調製方法としては、熱水抽出により抽出エキス液
を得て、これを原料として用い液状又は固体状製品の形
態にすることにした。この際、抽出エキス液はこれら3
剤の生薬自体又は粉砕品を各々熱水で抽出し、得られた
個々の抽出エキス液の混合液を原料とするか又は、又は
これら3つの生薬の同時混合物からの水抽出エキスを原
料とした。次に、原料として調製した抽出エキス液及び
最終製品のpHを種々に調製してその性状と保存安定性
を調べた。その結果、pHを1.5〜9.5に調整した
場合には、味、におい及び外観は実用に耐え得る共に保
存安定性が高いことが確認できた。即ち熱水で抽出する
際の抽出液のpHが1.5以下の酸性又は9.5以上の
塩基性においては、抽出過程で抽出液の色は暗色化し、
黒色沈殿を生じ、また樹脂臭等の異臭が生じる傾向が見
られ、保存時の時間の経過に伴って同様な変質傾向が見
られた。これに対してpHの範囲を1.5〜9.5に調
整した場合にはこのような変質傾向は抑制され、2.5
〜7.5ではより良好に、更に3.5〜5.5の範囲で
は非常に良好に抑制された。更に、胃癌及び大腸癌等の
消化器癌と診断された患者に本発明の医療用組成物を服
用させ、ガンに伴う諸症状である全身倦怠感、無気力、
息切れ、食欲不振、悪心、嘔吐及び腰痛等の改善効果を
自覚症状の問診により調べた。その結果、本発明3剤併
用例は比較対照の各生薬が単独又は2剤併用の場合に比
べて癌に伴う諸症状の改善効果が優れていることが分っ
た。本発明は以上の知見によって完成されたものであ
る。
First, as a method for preparing a solution or solid composition simultaneously containing three agents of Agaricus mushroom, Cordyceps sinensis or Reishi, an extract extract is obtained by hot water extraction, and the extract is prepared. We decided to use it as a raw material in the form of a liquid or solid product. At this time, the extracted extract solution
Each of the crude drug itself or the crushed product of the drug is extracted with hot water, and a mixture of the obtained individual extract extracts is used as a raw material, or a water extract from a simultaneous mixture of these three crude drugs is used as a raw material. . Next, the pH of the extract solution prepared as a raw material and the pH of the final product were variously adjusted, and their properties and storage stability were examined. As a result, it was confirmed that when the pH was adjusted to 1.5 to 9.5, the taste, odor and appearance were practically usable and the storage stability was high. That is, when the pH of the extract during extraction with hot water is acidic at 1.5 or less or basic at 9.5 or more, the color of the extract becomes dark during the extraction process,
There was a tendency that black precipitates were generated and an unpleasant odor such as resin odor was generated, and a similar deterioration tendency was observed with the lapse of time during storage. On the other hand, when the pH range is adjusted to 1.5 to 9.5, such alteration tendency is suppressed, and
At ~ 7.5, the suppression was more excellent, and further within the range of 3.5-5.5, the suppression was very good. Furthermore, patients who have been diagnosed with gastrointestinal cancers such as gastric cancer and colon cancer are allowed to take the medical composition of the present invention, and various symptoms associated with cancer such as general malaise, lethargy,
The effects of improving shortness of breath, anorexia, nausea, vomiting and back pain were examined by questioning of subjective symptoms. As a result, it was found that the three-drug combination example of the present invention was superior in the effect of improving various symptoms associated with cancer, as compared with the case where each crude drug as a control was used alone or in combination. The present invention has been completed based on the above findings.

【0005】以上により本発明の医療用組成物のpHの
調整範囲は1.5〜9.5であり、より好ましくは2.
5〜6.5、更に好ましくは3.5〜5.5の範囲であ
る。
[0005] As described above, the pH adjustment range of the medical composition of the present invention is 1.5 to 9.5, more preferably 2.
The range is from 5 to 6.5, more preferably from 3.5 to 5.5.

【0006】本発明において用いる生薬のアガリクス茸
(学名:アガリクス・ブラゼイ・リムル) はマッシュル
ームと同属の食用キノコであり、その産地は特に限定さ
れず人工栽培又は天然品のいずれでも良い。
[0006] Agaricus mushroom of crude drug used in the present invention
(Scientific name: Agaricus blazei Limulus) is an edible mushroom belonging to the same genus as mushrooms, and its production area is not particularly limited and may be either artificially cultivated or natural products.

【0007】本発明において用いる生薬の冬虫夏草は、
世界で350種ほど発見されているが、その産地及び種
類は特に限定されない。
[0007] Cordyceps, a crude drug used in the present invention,
About 350 species have been found in the world, but their origin and type are not particularly limited.

【0008】本発明において用いる生薬の霊芝(学名:
マンネンタケ)はサルノコシカケ科に属するキノコの一
種であり、その産地は限定されず人工栽培又は天然品の
いずれでも良い。
[0008] The crude drug used in the present invention, Reishi (scientific name:
Mannentake) is a kind of mushroom belonging to the family Sarcophaga and its production place is not limited, and may be either artificial cultivation or natural product.

【0009】本発明の組成物の製造は以下の様に実施す
る。即ち、アガリクス茸、冬虫夏草又は霊芝の各生薬又
はその粉砕品の各々、又は任意の割合のこれら3剤の混
合物を熱水に浸漬して、塩酸又は水酸化ナトリウム及び
pH安定剤の各種緩衝剤を加えてpHを1.5〜9.5
の範囲に調整し、一定時間放置して抽出する。この際、
各生薬が単独の場合には各抽出エキス液の混合液を調製
し原料として用い、また3剤を混合して同時に抽出した
抽出エキス液はそのまま原料として用いる。次に原料の
抽出エキス液に水溶性高分子を加えてゼリー状の組成物
を調製するか、抽出エキス液をそのまま又は糖類等の増
量剤を加えて凍結乾燥又は噴霧乾燥法によって乾燥して
粉末状態としこれに賦形剤を加えて顆粒や錠剤等の固形
状の組成物を調製する。更には、上記乾燥粉末又は顆粒
に風味の良い薬用又は食用植物の乾燥又は焙じた粉砕末
を混合してテイ−バックに充てんしお茶の形態の組成物
とする。
The preparation of the composition of the present invention is carried out as follows. That is, each of agaricus mushrooms, cordyceps sinensis or reishi herbal medicines or their crushed products, or a mixture of these three agents at an arbitrary ratio is immersed in hot water, and various buffers such as hydrochloric acid or sodium hydroxide and a pH stabilizer are used. To adjust the pH to 1.5 to 9.5.
And extract it by leaving it for a certain period of time. On this occasion,
When each crude drug is used alone, a mixed liquid of each extract is prepared and used as a raw material, and an extract extracted by mixing and simultaneously extracting three agents is directly used as a raw material. Next, a water-soluble polymer is added to the raw extract liquid to prepare a jelly-like composition, or the extract liquid is dried as is or by adding a bulking agent such as a saccharide and freeze-dried or spray-dried to obtain a powder. The composition is made into a state, and an excipient is added thereto to prepare a solid composition such as granules and tablets. Further, a dry or roasted pulverized powder of a medicinal or edible plant with good flavor is mixed with the above-mentioned dry powder or granules to be filled into a tea bag to obtain a composition in the form of tea.

【0010】上記の原料としての抽出エキス液のより具
体的な調製法としては、例えば以下の条件で抽出エキス
液及び乾燥原末を得ることができる。乾燥アガリクス
0.5〜1kg、乾燥霊芝粉砕末0.5〜1kg、乾燥
冬虫夏草粉砕0.5〜1kgの各々をそれぞれpH1.
5〜9.5の範囲に調整された100℃の熱水3〜6L
で各1時間ずつ4回浸漬抽出し、4回分の抽出液を合わ
せて1〜2Lまでに濃縮し抽出エキス液を得る。これら
3種の抽出液を種々な割合で混合し原料の抽出エキス液
とする。又は3剤混合品1〜3kg(乾燥アガリクスお
0.2〜1.5kg、乾燥霊芝粉砕末0.02〜0.4
kg、乾燥冬虫夏草粉砕0.2〜〜0.5kg)をpH
1.5〜9.5の範囲に調整された100℃熱水3〜6
Lに各1時間ずつ4回浸漬抽出し、4回分の抽出液を合
わせて1〜2Lまでに濃縮し原料の抽出エキス液とす
る。更に原料の抽出エキス液2Lに可溶性澱粉又はデキ
ストリン等を0.5〜1kg添加し凍結乾燥又は噴霧乾
燥して粉末化する。
As a more specific method of preparing the above-mentioned extract extract as a raw material, an extract extract and a dry bulk powder can be obtained, for example, under the following conditions. Each of 0.5 to 1 kg of dried agaricus, 0.5 to 1 kg of ground powder of dried Reishi, and 0.5 to 1 kg of ground powder of dried cordyceps each had a pH of 1.
3 to 6 L of hot water at 100 ° C. adjusted to the range of 5 to 9.5
The extract is immersed four times for 1 hour each, and the extracts of the four times are combined and concentrated to 1-2 L to obtain an extract extract. These three types of extracts are mixed at various ratios to obtain a raw material extract. Or a mixture of three agents 1-3 kg (dry agaricus 0.2-1.5 kg, dry reishi ground powder 0.02-0.4)
kg, dry caterpillar pulverized 0.2 ~ 0.5kg)
100 ° C. hot water 3 to 6 adjusted to the range of 1.5 to 9.5
L for 1 hour each for 4 extractions, and the combined extracts from the 4 extractions are combined and concentrated to 1 to 2 L to obtain the raw material extract. Further, 0.5 to 1 kg of soluble starch or dextrin is added to 2 L of the extract extract of the raw material, and freeze-dried or spray-dried to make a powder.

【0011】本発明の組成物の原料の抽出エキス液の抽
出時のpH調整剤は特に限定されないが製品のpHを安
定に保持するために緩衝効果のあるクエン酸、酒石酸、
リンゴ酸等の各種有機酸、リン酸及びホウ酸等の多塩基
無機酸を用いることが好ましい。
The pH adjuster at the time of extracting the extract extract of the raw material of the composition of the present invention is not particularly limited. However, citric acid, tartaric acid,
It is preferable to use various organic acids such as malic acid, and polybasic inorganic acids such as phosphoric acid and boric acid.

【0012】本発明の組成物の原料の抽出エキス液を粉
末化する際に加える増量剤及び顆粒や錠剤に成形する際
に用いる賦形剤は特に限定されないが、例えば澱粉類、
可溶性澱粉、蔗糖,果糖、マルトース、還元麦芽糖水
飴、キシリトール、エリスリトール、マンニトール、オ
リゴ糖、カオリン、含水二酸化珪素、軽質無水珪酸、合
成珪酸アルミニウム、結晶セルロース、硬化油、水酸化
アルミニウムゲル、珪藻土、酸化アルミニウム、炭酸マ
グネシウム、沈降炭酸カルシウム、軽質炭酸カルシウ
ム、デキストリン、複合珪酸アルミニウムカリウム粒、
ベントナイト、植物組織粉砕末、シクロデキストリン
類、珪酸マグネシウム、メタ珪酸アルミン酸マグネシウ
ム、トウモロコシ粉、グリセリルステアレート類及びリ
ン酸カルシウム等が挙げられる。
There are no particular restrictions on the extender added when powdering the extract extract of the raw material of the composition of the present invention and the excipient used when forming the granules or tablets, for example, starches,
Soluble starch, sucrose, fructose, maltose, reduced maltose syrup, xylitol, erythritol, mannitol, oligosaccharide, kaolin, hydrous silicon dioxide, light anhydrous silicic acid, synthetic aluminum silicate, crystalline cellulose, hardened oil, aluminum hydroxide gel, diatomaceous earth, oxidation Aluminum, magnesium carbonate, precipitated calcium carbonate, light calcium carbonate, dextrin, composite aluminum potassium silicate granules,
Examples include bentonite, ground powder of plant tissue, cyclodextrins, magnesium silicate, magnesium aluminate metasilicate, corn powder, glyceryl stearate, calcium phosphate, and the like.

【0013】本発明の組成物において、原料の抽出エキ
ス液に水溶性高分子を併用してゼリーの形態を調製する
方法としては、抽出エキス液の水希釈液を80℃前後の温
度に加温しておき、これに水溶性高分子のローカストビ
ーンガムとカラギーナンを併用して加え全体を均一な溶
液とした後に、任意の分包容器に充てんして冷却する。
この際、ローカストビーンガムとカラギーナンのグレー
ド及び添加量は特に限定されない
In the composition of the present invention, as a method for preparing a jelly form by using a water-soluble polymer in combination with a raw extract solution, a water dilution of the extract solution is heated to a temperature of about 80 ° C. Then, a mixture of water-soluble polymer locust bean gum and carrageenan is added to make a uniform solution, which is then filled in an arbitrary packaging container and cooled.
At this time, the grade and amount of locust bean gum and carrageenan are not particularly limited.

【0014】更に本発明の液状の組成物において用いら
れる増粘剤は特に限定されないが、例えばヒアルロン酸
及びその塩類、コンドロイチン硫酸及びこれらのアルカ
リ金属塩類、ヘパリン類似物質、コラーゲン、ゼラチ
ン、デキストン、メチルセルロース、ヒドロキシプロピ
ルセルロース、ヒドロキプロピルメチルセルロース及び
ポリエチレングリコール等の中性高分子、カルボキシメ
チルセルロースナトリウム、アルギン酸ナトリウム等の
天然高分子が挙げられる。
The thickener used in the liquid composition of the present invention is not particularly limited. Examples thereof include hyaluronic acid and salts thereof, chondroitin sulfate and alkali metal salts thereof, heparin-like substances, collagen, gelatin, dextone, and methylcellulose. And neutral polymers such as hydroxypropylcellulose, hydroxypropylmethylcellulose and polyethylene glycol; and natural polymers such as sodium carboxymethylcellulose and sodium alginate.

【0015】本発明の原料の抽出エキス液の調製に用い
る水は、蒸留水、水道水、地下水、精製水など衛生的な
ものであれば特に制限はないが、重金属や塩素の含量が
低い水を用いることがより好ましい。
The water used for preparing the extract extract of the raw material of the present invention is not particularly limited as long as it is sanitary, such as distilled water, tap water, groundwater, and purified water, but water having a low content of heavy metals and chlorine. It is more preferable to use

【0016】本発明の原料抽出エキス液の乾燥粉末又は
これを用いて調製された顆粒に風味の良い薬用又は食用
植物の乾燥又は焙じた粉砕末を混合してテイ−バックに
充てんしお茶の形態の組成物とする際の植物としては、
例えば高麗人参、アンデス人参、人参、鹿茸、当帰、ブ
ルーベリー、キダチアロエ、ザクロ、セサミン、石蓮
花、ガルシニア、シトラス、杜仲葉、ドクダミ、ハマ
葉、アマチャズル、ギムネマ、クコ葉、クコ実、山査
子、甘草、蓮の葉、クマザサ、ウーロン、ビワ葉、ハト
ムギ、陳皮、冬葵子、赤芽柏、山梔子、カキ葉、ハブ
葉、モロヘイヤ、ウコン、甜茶、イチョウ葉、マイタ
ケ、ノコギリヤシエキス、アンズ、アズキ、アカメガシ
ワ、ベニバナ、ビワ、ボタン、マイタケ、ダイズ、エン
ジュ、フキ、タンポポ、ゲンノショウコ、ゴボウ、ハブ
ソウ、ハッカ、ハナミョウガ、ホオノキ、カキノハ、カ
リン、カシワ、ヨモギ、イチョウ、ケイヒ、キハダ、キ
キョウ、キンカチャ、クチナシ、コショウ、クヌギ、ク
ワ、クズ、クミスチン、カンピ、モクレン、モモ、ナツ
メ、ナガイモ、ニワトコ、ノイバラ、オケラ、オオバ
コ、オタネニンジン、ラッキョウ、レンギョウ、サイカ
チ、サクラ、サンシュユ、ササ、センキュウ、シャクヤ
ク、ショウガ、スイカズラ、スモモ、タケ、チャ、ウー
ロンチャ、ユチャ、トウキ、ウド、ウイキョウ、ウメ、
ワレモコウ、ヤマゴボウ、ヤマモモ、ユリ、ナンテン、
ユキノシタ、カキドオシ、ヨモギ、オオバコ、ツユク
サ、アザミ、アマチャ、ナデシコ、ハギ、ミント、カミ
ツレ、ニンニク、アシタバ、アマチャズル、エビスグ
サ、タイヨウトウ、カキ、カンゾウ、ギムネマ・シルベ
スタ、ガルシニア・カンボジア、アノーフウ.ムリカー
タ(トゲハンレイシ)、センブリ、タヒボ、ドクダミ、
ナナチャ、ハトムギ、ヒバ、ホウレン草、モロヘイヤ、
シソの各々を単独に又は二種以上を併用して用いられ
る。
Dry tea powder of the raw material extract extract of the present invention or granules prepared using the same is mixed with a pulverized powder obtained by drying or roasting a medicinal or edible plant having good flavor and filling into a tea bag to form tea. As a plant when making the composition of,
For example, ginseng, andes ginseng, ginseng, deer mushroom, toki, blueberry, kidachi aloe, pomegranate, sesamin, stone lotus flower, garcinia, citrus, tochuha, dokudami, hama leaf, achachazul, gymnema, wolfberry, wolfberry, yamako, licorice , Lotus leaf, kumazasa, oolong, loquat leaf, barley, cinnamon, winter aoi, red bud, garland, oyster leaf, hub leaf, moloheiya, turmeric, sweet tea, ginkgo leaf, maitake, saw palmetto extract, apricot, azuki, akamegashiwa, Safflower, loquat, button, maitake, soybean, engju, butterbur, dandelion, gennoshoko, burdock, haw sow, mentha, hanamyoga, honoki, kakinoha, karin, kasiwa, mugwort, ginkgo, keihi, kihada, kikyo, kinkacha, kuchinashi, kochinashi Kunugi, Mulberry, Kudzu, Kumistin, Kang , Magnolia, peach, jujube, yam, elderberry, wild rose, pokera, psyllium, panax ginseng, rakkyo, forsythia, honey locust, cherry blossom, sanshuyu, sasa, senkyu, peonies, ginger, honeysuckle, plum, bamboo shoot, cha, oolongcha, yulongcha Touki, Udo, Fennel, Plum,
Waremokou, pokeweed, bayberry, lily, nanten,
Saxifraga, persimmon, mugwort, psyllium, twigweed, thistle, amacha, nadesico, hagi, mint, chamomile, garlic, ashitaba, amachazur, ibisgussa, taiyouto, oyster, kanzo, gimnema sylvestia, garcinia kanbobo. Murikata (barbet reed), assembly, tahibo, dokudami,
Nanana, Adlay, Hiba, Spinach, Moloheiya,
Each of the perilla is used alone or in combination of two or more.

【0017】[0017]

【発明の効果】【The invention's effect】

【0018】実験例.1. アガリクス茸、冬虫夏草及び霊芝を同時に含む水溶液製
品の性状の調製時又は保存時におけるpH変化。 (1).試料及び観察方法。 アガリクスエキス末1.2kg、霊芝エキス末0.3k
g、冬虫夏草エキス末0.4kgを100℃の熱水4.
5Lに各1時間各4回浸漬し、抽出液計16Lを濃縮し
て2Lとした。この抽出安息香酸ナトリウム20g及び
クエン酸200gを加え、8等分し、その各々について
1Nの塩酸又は水酸化ナトリウムを用いてpHを1.
0、1.5、3.0、5.5、7.5、9.5、10.
0及び10.5に調整し、無色透明ガラス瓶に充てん密
封し室温に保存し、調製時及び保存12ヶ月後のpH、
色、におい、味及び服用の可否について観察した。 (3)観察結果 表1及び2に結果を示した。アガリクス茸、冬虫夏草又
は霊芝の各生薬又はこれら3つの生薬の混合物からの水
抽出エキスを調製する際のpHを1.5〜9.5に調整
した場合には、抽出エキスの味、におい及び外観は共に
保存安定性が良好で、アガリクス茸、冬虫夏草及び霊芝
の各生薬を混合し熱水で抽出する際の抽出液のpHが
1.5以下の酸性又は9.5以上の塩基性においては、
抽出過程で抽出液の色は暗色化し、黒色沈殿を生じ、ま
た樹脂臭等の異臭が生じる。また、各生薬を単独に同条
件で抽出した場合にはこのような現象は見られないが各
抽出液を混合して保存すると時間の経過に伴って同様な
変質傾向が見られた。 表 1 表 2
Experimental example. 1. Changes in pH during preparation or storage of properties of an aqueous product containing Agaricus mushroom, Cordyceps and Reishi. (1). Sample and observation method. Agaricus extract powder 1.2kg, Reishi extract powder 0.3k
g, Cordyceps sinensis extract powder (0.4 kg) in hot water at 100 ° C.
Each was immersed 4 times in 5 L for 1 hour each, and 16 L of extract liquid was concentrated to 2 L. 20 g of this extracted sodium benzoate and 200 g of citric acid are added, and the mixture is divided into eight equal portions, and each of them is adjusted to pH 1. using 1N hydrochloric acid or sodium hydroxide.
0, 1.5, 3.0, 5.5, 7.5, 9.5, 10.
Adjusted to 0 and 10.5, filled in a colorless transparent glass bottle, sealed and stored at room temperature, pH at the time of preparation and 12 months after storage,
Observations were made on color, smell, taste, and whether or not it could be taken. (3) Observation results Tables 1 and 2 show the results. Agaricus mushroom, Cordyceps sinensis or Ganoderma herbs or a mixture of these three crude drugs, when preparing a water-extracted extract from 1.5 to 9.5, the taste, smell and Both appearances have good storage stability, and the pH of the extract when mixing the agaricus mushrooms, Cordyceps sinensis and Ganoderma herbs and extracting with hot water is 1.5 or less acidic or 9.5 or more basic. Is
During the extraction process, the color of the extract becomes dark, black precipitates are formed, and an unusual odor such as resin odor is generated. When each crude drug was extracted alone under the same conditions, such a phenomenon was not observed. However, when each extract was mixed and stored, the same tendency of deterioration was observed with the passage of time. Table 1 Table 2

【0019】実験例.2.胃癌と診断された患者におけ
る投与試験 (1).試料。 本発明の実施例1で調製した液体飲料、1回1瓶。 (2).投与・観察方法 胃癌と診断された患者7名に1日3回、食前に服用、1
ヶ月連続投与。投与中及び投与後の患者の自覚症状を問
診により観察した。全身倦怠、無気力、息切れ、食欲不
振、悪心嘔吐、発汗及び腰痛等の癌に伴う諸症状を問診
した。 (3)観察結果 表3に症状の改善を示した患者の例数を示した。本発明
の3剤併用例は、生薬が単独又は2剤併用の場合に比べ
て、胃癌患者の全身倦怠、無気力、息切れ、食欲不振、
悪心嘔吐、発汗及び腰痛等の癌に伴う諸症状の改善効果
が優れている。 表 3
Experimental example. 2. Administration test in patients diagnosed with gastric cancer (1). sample. The liquid beverage prepared in Example 1 of the present invention, one bottle at a time. (2). Administration / Observation method Take 7 doses before meals 3 times a day for 7 patients diagnosed with gastric cancer.
Monthly administration. Patients' subjective symptoms during and after administration were observed by interview. The patient was asked about various symptoms associated with cancer, such as general malaise, lethargy, shortness of breath, anorexia, nausea and vomiting, sweating and back pain. (3) Observation results Table 3 shows the number of patients who showed improvement in symptoms. The three-drug combination example of the present invention, compared with the case where the herbal medicine is used alone or in combination with two drugs, systemic malaise, lethargy, shortness of breath, anorexia,
It is excellent in improving various symptoms associated with cancer such as nausea and vomiting, sweating and back pain. Table 3

【0020】[0020]

【実施例】次に本発明のガン治療用ガン治療用組成物の
処方及び治療効果について、実施例をあげて具体的に説
明する。
EXAMPLES Next, the formulation and therapeutic effect of the composition for cancer treatment of the present invention will be described in detail with reference to examples.

【0021】[0021]

【実施例1】 水抽出物の液体飲料 アガリクスエキス末1.2kg、霊芝エキス末0.3k
g、冬虫夏草エキス末0.4kgを100℃の熱水4.
5Lに各1時間各4回浸漬し、抽出液計16Lを濃縮し
て2Lとした。この抽出液に可溶解性澱粉0.5kgを
加え、噴霧乾燥し抽出エキス粉末とした。抽出エキス粉
末1kg、安息香酸ナトリウム20g、エリスルトール
1kg、クエン酸0.8kg、オリゴ糖0.2kg、精
製水6.98Lを60℃2時間で混合溶解し、pHを
3.8〜4.2に調整し、90℃30分で3回加熱殺菌
し10mLずつ瓶に充てんし製品とした。
Example 1 Liquid drink of water extract Agaricus extract powder 1.2 kg, Reishi extract powder 0.3 k
g, Cordyceps sinensis extract powder (0.4 kg) in hot water at 100 ° C.
Each was immersed 4 times in 5 L for 1 hour each, and 16 L of extract liquid was concentrated to 2 L. 0.5 kg of soluble starch was added to this extract and spray-dried to obtain an extract powder. 1 kg of the extract powder, 20 g of sodium benzoate, 1 kg of erythritol, 0.8 kg of citric acid, 0.2 kg of oligosaccharide, and 6.98 L of purified water were mixed and dissolved at 60 ° C. for 2 hours to adjust the pH to 3.8 to 4.2. The product was adjusted, sterilized by heating three times at 90 ° C. for 30 minutes, and filled into bottles in 10 mL portions to obtain a product.

【0022】[0022]

【実施例2】 顆粒 実施例1で得た噴霧乾燥し抽出エキス粉末10質量部、
乳糖60質量部、トウモロコシ澱粉28質量部及びポリ
ビニルピロリドンK30 2質量部を良く混合し、50
%エタノールを造粒溶媒として押し出し造粒機で造粒乾
燥し、20〜50メッシの粒度の顆粒を調製し、この2
gずつを両面メタルSPパッケージし製品とした。
Example 2 Granules 10 parts by mass of the spray-dried extract powder obtained in Example 1,
60 parts by weight of lactose, 28 parts by weight of corn starch and 2 parts by weight of polyvinylpyrrolidone K30 are mixed well,
% Ethanol as a granulating solvent and granulated and dried by a granulator to prepare granules having a particle size of 20 to 50 Messi.
g of each product was packaged on both sides of the metal SP package.

【0023】[0023]

【実施例3】お茶 実施例2で得た顆粒20質量部、焙じたハトムギ粉砕末
30質量部、 杜仲葉末30質量部及びクコ葉20質量
部を均一に混合する。この混合粉末の10gをテイーバ
ッグに充てんし、お茶の製品とする。
Example 3 Tea 20 parts by mass of the granules obtained in Example 2, 30 parts by mass of ground pulverized powder of pearl barley, 30 parts by mass of Tonaka leaf powder and 20 parts by mass of wolfberry leaf are mixed uniformly. 10 g of this mixed powder is filled into a tea bag to make a tea product.

【0024】[0024]

【実施例4】 ゼリー製品 実施例で得た抽出エキス液に水リットル、この抽出エキ
ス液の97質量部にローカストビーンガム1質量部及び
カラギーナン0.5質量部を加え、80℃に加熱しつ
つ、均一な溶液とし、これを各20mLづつ、ポリエチ
レン製のポシェット容器に充てんし冷却してゼリー製品
とする。
Example 4 Jelly product Water liter was added to the extract solution obtained in the example, 1 part by mass of locust bean gum and 0.5 part by mass of carrageenan were added to 97 parts by mass of the extract solution, and the mixture was heated to 80 ° C. A 20 ml of each solution was filled into a polyethylene pochette container and cooled to obtain a jelly product.

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 35/00 A61P 35/00 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61P 35/00 A61P 35/00

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】アガリクス茸、冬虫夏草及び霊芝の抽出エ
キスを同時に含み、液状製品又は固体状製品の水溶液・
水分散液のpHが1.5〜9.5である医療用組成物
1. An aqueous solution of a liquid product or a solid product which simultaneously contains an extract of Agaricus mushroom, Cordyceps and Reishi.
The medical composition wherein the pH of the aqueous dispersion is 1.5 to 9.5.
【請求項2】形態が水溶液剤又はゼリー剤、顆粒剤、錠
剤である請求項1の医療用組成物
2. The medical composition according to claim 1, which is in the form of an aqueous solution or a jelly, a granule or a tablet.
【請求項3】形態が薬用又は食用植物の乾燥又は焙じた
粉砕末を加えたお茶である請求項1の医療用組成物
3. The medical composition according to claim 1, wherein the composition is tea to which a pulverized powder obtained by drying or roasting a medicinal or edible plant is added.
JP2000117923A 2000-04-19 2000-04-19 Composition for medicament Pending JP2001302535A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000117923A JP2001302535A (en) 2000-04-19 2000-04-19 Composition for medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000117923A JP2001302535A (en) 2000-04-19 2000-04-19 Composition for medicament

Publications (1)

Publication Number Publication Date
JP2001302535A true JP2001302535A (en) 2001-10-31

Family

ID=18629161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000117923A Pending JP2001302535A (en) 2000-04-19 2000-04-19 Composition for medicament

Country Status (1)

Country Link
JP (1) JP2001302535A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007159511A (en) * 2005-12-15 2007-06-28 Atsushi Umemura Health food and health tea
CN103169781A (en) * 2013-03-12 2013-06-26 翁捷 Pharmaceutical composition for treating brain tumor
JP2013538219A (en) * 2010-09-17 2013-10-10 江中▲薬▼▲業▼股▲ふん▼有限公司 Application of herbal medicine composition to the preparation of health foods and medicines for the relief and prevention treatment of physical fatigue
CN107751980A (en) * 2017-09-05 2018-03-06 马鞍山市安康菌业有限公司 A kind of preparation method of nourishment for vitality buccal tablet
JP2018177690A (en) * 2017-04-13 2018-11-15 雄二 松川 Parasympathetic dominant lymphocyte activated antitumor agent and method for producing the same
JP2018188412A (en) * 2017-05-12 2018-11-29 雄二 松川 Parasympathetic nerve dominance and lymphocyte activation upper gastrointestinal tract-mucosal absorption antitumor agent by upper gastrointestinal tract-mucosal absorption
CN110496141A (en) * 2019-09-10 2019-11-26 杭州华东医药集团新药研究院有限公司 A kind of pharmaceutical composition containing cordyceps sinensis

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007159511A (en) * 2005-12-15 2007-06-28 Atsushi Umemura Health food and health tea
JP2013538219A (en) * 2010-09-17 2013-10-10 江中▲薬▼▲業▼股▲ふん▼有限公司 Application of herbal medicine composition to the preparation of health foods and medicines for the relief and prevention treatment of physical fatigue
US8986750B2 (en) 2010-09-17 2015-03-24 Jiangzhong Pharmaceutical Co., Ltd. Use of a traditional chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue
CN103169781A (en) * 2013-03-12 2013-06-26 翁捷 Pharmaceutical composition for treating brain tumor
JP2018177690A (en) * 2017-04-13 2018-11-15 雄二 松川 Parasympathetic dominant lymphocyte activated antitumor agent and method for producing the same
JP2018188412A (en) * 2017-05-12 2018-11-29 雄二 松川 Parasympathetic nerve dominance and lymphocyte activation upper gastrointestinal tract-mucosal absorption antitumor agent by upper gastrointestinal tract-mucosal absorption
CN107751980A (en) * 2017-09-05 2018-03-06 马鞍山市安康菌业有限公司 A kind of preparation method of nourishment for vitality buccal tablet
CN110496141A (en) * 2019-09-10 2019-11-26 杭州华东医药集团新药研究院有限公司 A kind of pharmaceutical composition containing cordyceps sinensis

Similar Documents

Publication Publication Date Title
ES2272343T3 (en) COMPOSITION OF WITHANIA SOMNIFERA.
US10111925B2 (en) Formulations comprising plant extracts
KR20140118279A (en) Oral cleansing composition fermented taraxacum extract-containing complex herbal extract
US20150290268A1 (en) Formulations comprising herbal extracts
SA06270470B1 (en) A composition of traditional Chinese medicine for treating headache, the preparations and the process making the same
CN105142424A (en) Cereal containing hericium erinaceum and method for making same
JP2016532446A (en) Enbu fermented food or beverage composition
JP2001302535A (en) Composition for medicament
CN101618146A (en) Complex traditional Chinese medicine preparation for treating upper respiratory tract infection and preparation method thereof
CN114747760A (en) Composition for preventing or improving upper respiratory tract infection and application thereof
CN105663014A (en) Inflammation diminishing and whitening toothpaste containing rhizoma coptidis and fresh ginger
KR20170000902A (en) Composition for growth promotion comprising herb extracts and formulation
RU2563190C2 (en) Medication based on dry extracts of medicinal plants and method of obtaining thereof (versions)
EP3441076A1 (en) Pharmaceutical product for treating tumor and combined immune defect, and preparation and application thereof
DE102008059070B4 (en) A composition for the therapeutic or prophylactic treatment of diarrheal diseases and / or for the maintenance and / or restoration of the natural intestinal flora, dosage unit, packaging unit and use of the composition
US9895406B2 (en) Homeopathic remedies and methods for enhancing weight loss
EP4255443A1 (en) Stable semi-solid chewable gel compositions and methods of making and using thereof
CN107115295A (en) A kind of fluid composition containing cordyceps sinensis and preparation method thereof
CN107308213A (en) A kind of fig effervescent tablet and its production method
RU2182011C1 (en) Biologically active food additive to prevent reduction of immune system
CN107595870B (en) Brain-strengthening and nerve-soothing pharmaceutical composition, pharmaceutical preparation, application and preparation method
CN102247331B (en) Cefadroxil chewable tablets and preparation method thereof
CN106063788A (en) Phillyrin, phillyrin derivant, phillyrin are alleviated or/and the application in medicine or health product is vomitted in treatment in preparation with phillygenol compositions
EP3129031B1 (en) Composition for treating stomach pain
KR101458670B1 (en) Pharmaceutical composition comprising branched chain amino acids as active ingredients and the preparation method thereof